Castleman’s disease with TAFRO syndrome: The first case from Iran

سال انتشار: 1397
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 463

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

ISMOH17_001

تاریخ نمایه سازی: 10 اردیبهشت 1398

چکیده مقاله:

Introduction: TAFRO syndrome is new presentation of idiopathic multicentric Castlemandisease which is termed as thrombocytopenia, anasarca, fever, reticulinmyelofibrosis andorganomegaly. The exact pathophysiology of TAFRO syndrome is unclear and management ismostly based on case reports and expert opinion.Materials Methods: Histologic findings of bone marrow, skin, kidney and lymph node biopsyand other laboratory findings of the 37 year old male has been provided.Results: The patient was referred with fever, sweating, anorexia, abdominal distension andgeneralized edema which has been hospitalized multiple times. The patient also developed skinlesions dispersed in red nodules, which was reported as granuloid hemangioma Renal biopsyreported mesangioprolifrative glomerulonephritis and bone marrow specimen showed hypercellularmarrow with reticulin fibrosis. The lymph node biopsy was reported as Castleman disease.Conclusions: Different manifestations of TAFRO syndrome may overlap with other syndromes andcan be managed by corticosteroids, tocilizumab, retuximab, and bortezomib.

نویسندگان

Seyede Tahereh Mohaddess

Assistant Professor, Division of hematology oncology, department of internal medicine,Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad ,Iran

Zahra Rezaei Borojerdi

Internal Medicine Resident, Division of Hematology Oncology, Department of Internal Medicine,Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad ,Iran

Abbas Shirdel

Hematology Oncology Fellowship, Division of Hematology Oncology, Department of Internal Medicine,Faculty of Medicine, Mashhad, Iran.

Mohammad Moeini Nodeh

Professor of Hematology and Oncology, Division of Hematology Oncology, Department of InternalMedicine, Faculty of Medicine, Mashhad, Iran